The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Adiponectin Stimulates RANKL and Inhibits OPG Expression in Human Osteoblasts Through the MAPK Signaling Pathway
Abstract
Our study indicates that recombinant adiponectin induced RANKL and inhibited OPG expression in human osteoblasts through the AdipoR1/p38 MAPK pathway, and these responses contributed to the adiponectin-induced osteoclasts formation in the co-culture of osteoblast and peripheral blood monocytes systems. These findings showed that adiponectin increased osteoclast formation indirectly through stimulating RANKL and inhibiting OPG production in osteoblasts. It also suggests the pharmacological nature of recombinant adiponectin that indirectly induces osteoclasts formation. Introduction: Recently, adiponectin has emerged as an element in the regulation of bone metabolism, but the mechanism remains. This study was undertaken to investigate the action of adiponectin on osteoclastogenesis through revealing RANKL and osteoprotegerin (OPG) expression in osteoblasts and osteoclast formation. Materials and Methods: Real-time quantitative PCR and ELISA were used to detect RANKL and OPG mRNA and protein expression in cultured human osteoblasts. The involved signal pathway was studied using mitogen-activated protein kinase (MAPK) inhibitor and adiponectin receptor 1 (AdipoR1) siRNA. The effects of recombinant adiponectin on osteoclasts formation also were examined in the co-culture systems of osteoblast and peripheral blood monocytes (PBMCs) systems or purified CD14 + PBMCs cultures. Results: Our study showed that recombinant adiponectin induced RANKL and inhibited OPG mRNA expression in human osteoblasts in a dose- and time-dependent manner. Adiponectin also increased soluble RANKL and decreased OPG secretion in osteoblasts conditioned media. Suppression of AdipoR1 with siRNA abolished the adiponectin-regulated RANKL and OPG mRNA expression in osteoblasts. Furthermore, pretreatment of osteoblasts with the MAPK inhibitor SB203580 abolished adiponectin-regulated RANKL and OPG mRNA expression. Adiponectin induced osteoclast formation in the co-culture systems of osteoblast and PBMCs systems, and OPG entirely blocked this response. However, adiponectin had no direct effect on the differentiation of osteoclast precursor purified CD14 + PBMCs. Conclusions: These data indicate that recombinant adiponectin induced RANKL and inhibited OPG expression in human osteoblasts through the AdipoR1/p38 MAPK pathway, and these responses contributed to the adiponectin-induced osteoclast formation in the co-culture of osteoblast and PBMCs systems. These findings showed that adiponectin increased osteoclast formation indirectly through stimulating RANKL and inhibiting OPG production in osteoblasts. It suggests the pharmacological nature of recombinant adiponectin that indirectly induces osteoclasts formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Seger, R., & Krebs, E. G. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.9.7601337 · Cited by 3,602
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 1×
“Injection of exogenous RANKL in mice induces an osteoporotic phenotype, and RANKL knockout mice have severe osteopetrosis,((25)) whereas OPG attaches to RANKL, thereby blocking osteoclastogenesis.”
BackgroundA Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
MAPK signal pathways in the regulation of cell proliferation in mammalian cells
ZHANG, W., & LIU, H. T. (2002) · Cell Research · doi:10.1038/sj.cr.7290105 · Cited by 2,845
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,083
Minireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515
Isolation and Characterization of GBP28, a Novel Gelatin-Binding Protein Purified from Human Plasma
Nakano, Y., Tobe, T., Choi-Miura, N.-H., Mazda, T., & Tomita, M. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021483 · Cited by 916
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
Mizuno, A., Amizuka, N., Irie, K., Murakami, A., Fujise, N., Kanno, T., Sato, Y., Nakagawa, N., Yasuda, H., Mochizuki, S.-I., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8697 · Cited by 775
Robey, P. G., & Termine, J. D. (1985) · Calcified Tissue International · doi:10.1007/bf02557826 · Cited by 694
Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology
Hofbauer, L. C., & Heufelder, A. E. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100226 · Cited by 586
Franceschi, R. T., & Xiao, G. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10369 · Cited by 541
Adiponectin and its receptors are expressed in bone-forming cells
Berner, H. S., Lyngstadaas, S. P., Spahr, A., Monjo, M., Thommesen, L., Drevon, C. A., Syversen, U., & Reseland, J. E. (2004) · Bone · doi:10.1016/j.bone.2004.06.008 · Cited by 508
Takahashi, N., Udagawa, N., & Suda, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0252 · Cited by 463
Leptin Inhibits Osteoclast Generation
Holloway, W. R., Collier, F. M., Aitken, C. J., Myers, D. E., Hodge, J. M., Malakellis, M., Gough, T. J., Collier, G. R., & Prof. Nicholson, G. C. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.2.200 · Cited by 440
Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast
Oshima, K., Nampei, A., Matsuda, M., Iwaki, M., Fukuhara, A., Hashimoto, J., Yoshikawa, H., & Shimomura, I. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.210 · Cited by 400
Luo, X.-H., Guo, L.-J., Yuan, L.-Q., Xie, H., Zhou, H.-D., Wu, X.-P., & Liao, E.-Y. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.05.021 · Cited by 352
Self-citationParathyroid hormone-dependent signaling pathways regulating genes in bone cells
Swarthout, J. T., D'Alonzo, R. C., Selvamurugan, N., & Partridge, N. C. (2002) · Gene · doi:10.1016/s0378-1119(01)00798-3 · Cited by 340
Sequential protein kinase reactions controlling cell growth and differentiation
Johnson, G. L., & Vaillancourt, R. R. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90141-4 · Cited by 335
Aubin, J. E., & Bonnelye, E. (2000) · Osteoporosis International · doi:10.1007/s001980070028 · Cited by 319
Adiponectin as a novel determinant of bone mineral density and visceral fat
Lenchik, L., Register, T. C., Hsu, F.-C., Lohman, K., Nicklas, B. J., Freedman, B. I., Langefeld, C. D., Carr, J. J., & Bowden, D. W. (2003) · Bone · doi:10.1016/s8756-3282(03)00237-0 · Cited by 306
Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways
Shinoda, Y., Yamaguchi, M., Ogata, N., Akune, T., Kubota, N., Yamauchi, T., Terauchi, Y., Kadowaki, T., Takeuchi, Y., Fukumoto, S., et al. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20890 · Cited by 284
MAPK signal pathways in the regulation of cell proliferation in mammalian cells
ZhanW, & LiuHT (2002) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 216
Adiponectin is Associated with Bone Mineral Density in Perimenopausal Women
Jürimäe, J., Rembel, K., Jürimäe, T., & Rehand, M. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-861483 · Cited by 126
Nicholson, G. C., Malakellis, M., Collier, F., Cameron, P. U., Holloway, W. R., Gough, T. J., Gregorio-King, C. C., Kirkland, M. A., & Myers, D. E. (2000) · PubMed · Cited by 119
Transforming growth factor-β induces osteoclast formation in the absence of RANKL
Itonaga, I., Sabokbar, A., Sun, S. G., Kudo, O., Danks, L., Ferguson, D. J. P., Fujikawa, Y., & Athanasou, N. A. (2003) · Bone · doi:10.1016/j.bone.2003.08.008 · Cited by 119
NICHOLSON, G. C., MALAKELLIS, M., COLLIER, F. M., CAMERON, P. U., HOLLOWAY, W. R., GOUGH, T. J., GREGORIO-KING, C., KIRKLAND, M. A., & MYERS, D. E. (2000) · Clinical Science · doi:10.1042/cs0990133 · Cited by 107
Nakamura, T., Scorilas, A., Stephan, C., Yousef, G. M., Kristiansen, G., Jung, K., & Diamandis, E. P. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600869 · Cited by 91
Cheung, J., Mak, Y. T., Papaioannou, S., Evans, B. A., Fogelman, I., & Hampson, G. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1770423 · Cited by 88
Ishida, A., Fujita, N., Kitazawa, R., & Tsuruo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111093200 · Cited by 87
Nakayamada, S., Okada, Y., Saito, K., Tamura, M., & Tanaka, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308786200 · Cited by 84
Annexin II Stimulates RANKL Expression Through MAPK
Li, F., Chung, H.-Y., Reddy, S. V., Lu, G., Kurihara, N., Zhao, A. Z., & Roodman, G. D. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050207 · Cited by 60
Kusumi, A., Sakaki, H., Kusumi, T., Oda, M., Narita, K., Nakagawa, H., Kubota, K., Satoh, H., & Kimura, H. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-005-0615-6 · Cited by 57
Liao, E. Y., Luo, X., & Su, X. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03345513 · Cited by 32
Self-citationLiao, E.-Y., & Luo, X. (2001) · Endocrine · doi:10.1385/endo:15:3:291 · Cited by 26
Self-citation
Cited by
De Souza, M. J., Nattiv, A., Joy, E., Misra, M., Williams, N. I., Mallinson, R. J., Gibbs, J. C., Olmsted, M., Goolsby, M., Matheson, G., et al. (2014) · British Journal of Sports Medicine · doi:10.1136/bjsports-2013-093218 · Cited by 661
Relationships between fat and bone
Reid, I. R. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0492-z · Cited by 475
The role of resistin as a regulator of inflammation: Implications for various human pathologies
Filková, M., Haluzík, M., Gay, S., & Šenolt, L. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.07.013 · Cited by 451
Ma, L., Oei, L., Jiang, L., Estrada, K., Chen, H., Wang, Z., Yu, Q., Zillikens, M. C., Gao, X., & Rivadeneira, F. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9674-x · Cited by 412
Endocrine consequences of anorexia nervosa
Misra, M., & Klibanski, A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70180-3 · Cited by 341
Metadata
- Authors
- Luo, X.-H., Guo, L.-J., Xie, H., Yuan, L.-Q., Wu, X.-P., Zhou, H.-D., & Liao, E.-Y.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-10-01
- Volume
- 21
- Issue
- 10
- Pages
- 1648-1656
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2049409177
- Cited by
- 369
- References
- 37
- FWCI
- 6.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.